Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JoEllen Welsh

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
BMC Genomics|October 30, 2009
Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-downJosé L Costa, Paul P Eijk, Mark A van de Wiel, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 31, 2019
Highlights from the 21st Workshop on Vitamin D in Barcelona, May 2018James C Fleet, Moray J Campbell, Carsten Carlberg, et al.
Cancer Investigation|August 31, 2012
Buthionine sulfoximine and 1,25-dihydroxyvitamin D induce apoptosis in breast cancer cells via induction of reactive oxygen speciesLuciana P Bohl, Ana C Liaudat, Gabriela Picotto, et al.
Journal of Cellular Biochemistry|February 19, 2014
Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1Steve Y Rhieu, Andrew J Annalora, Erika LaPorta, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 21, 2020
VDR in salivary gland homeostasis and cancerKara A DeSantis, Samantha L Robilotto, Mark Matson, et al.
Molecular Cell|March 18, 2006
The molecular basis of vitamin D receptor and beta-catenin crossregulationSalimuddin Shah, Md Naimul Islam, Sivanesan Dakshanamurthy, et al.
BMC Cancer|March 19, 2013
Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic cultureCintia Milani, Maria Lucia Hirata Katayama, Eduardo Carneiro de Lyra, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
BMC Genomics|October 30, 2009
Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-downJosé L Costa, Paul P Eijk, Mark A van de Wiel, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 31, 2019
Highlights from the 21st Workshop on Vitamin D in Barcelona, May 2018James C Fleet, Moray J Campbell, Carsten Carlberg, et al.
Cancer Investigation|August 31, 2012
Buthionine sulfoximine and 1,25-dihydroxyvitamin D induce apoptosis in breast cancer cells via induction of reactive oxygen speciesLuciana P Bohl, Ana C Liaudat, Gabriela Picotto, et al.
Journal of Cellular Biochemistry|February 19, 2014
Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1Steve Y Rhieu, Andrew J Annalora, Erika LaPorta, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 21, 2020
VDR in salivary gland homeostasis and cancerKara A DeSantis, Samantha L Robilotto, Mark Matson, et al.
Molecular Cell|March 18, 2006
The molecular basis of vitamin D receptor and beta-catenin crossregulationSalimuddin Shah, Md Naimul Islam, Sivanesan Dakshanamurthy, et al.
BMC Cancer|March 19, 2013
Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic cultureCintia Milani, Maria Lucia Hirata Katayama, Eduardo Carneiro de Lyra, et al.
Pageof 8